APA
Root A. R., Cao W., Li B., LaPan P., Meade C., Sanford J., Jin M., O'Sullivan C., Cummins E., Lambert M., Sheehan A. D., Ma W., Gatto S., Kerns K., Lam K., D'Antona A. M., Zhu L., Brady W. A., Benard S., King A., He T., Racie L., Arai M., Barrett D., Stochaj W., LaVallie E. R., Apgar J. R., Svenson K., Mosyak L., Yang Y., Chichili G. R., Liu L., Li H., Burke S., Johnson S., Alderson R., Finlay W. J. J., Lin L., Olland S., Somers W., Bonvini E., Gerber H., May C., Moore P. A., Tchistiakova L. & Bloom L. (2016). Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. : Antibodies (Basel, Switzerland).
Chicago
Root Adam R, Cao Wei, Li Bilian, LaPan Peter, Meade Caryl, Sanford Jocelyn, Jin Macy, O'Sullivan Cliona, Cummins Emma, Lambert Matthew, Sheehan Alfredo D, Ma Weijun, Gatto Scott, Kerns Kelvin, Lam Khetemenee, D'Antona Aaron M, Zhu Lily, Brady William A, Benard Susan, King Amy, He Tao, Racie Lisa, Arai Maya, Barrett Dianah, Stochaj Wayne, LaVallie Edward R, Apgar James R, Svenson Kristine, Mosyak Lidia, Yang Yinhua, Chichili Gurunadh R, Liu Liqin, Li Hua, Burke Steve, Johnson Syd, Alderson Ralph, Finlay William J J, Lin Laura, Olland Stéphane, Somers William, Bonvini Ezio, Gerber Hans-Peter, May Chad, Moore Paul A, Tchistiakova Lioudmila and Bloom Laird. 2016. Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. : Antibodies (Basel, Switzerland).
Harvard
Root A. R., Cao W., Li B., LaPan P., Meade C., Sanford J., Jin M., O'Sullivan C., Cummins E., Lambert M., Sheehan A. D., Ma W., Gatto S., Kerns K., Lam K., D'Antona A. M., Zhu L., Brady W. A., Benard S., King A., He T., Racie L., Arai M., Barrett D., Stochaj W., LaVallie E. R., Apgar J. R., Svenson K., Mosyak L., Yang Y., Chichili G. R., Liu L., Li H., Burke S., Johnson S., Alderson R., Finlay W. J. J., Lin L., Olland S., Somers W., Bonvini E., Gerber H., May C., Moore P. A., Tchistiakova L. and Bloom L. (2016). Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. : Antibodies (Basel, Switzerland).
MLA
Root Adam R, Cao Wei, Li Bilian, LaPan Peter, Meade Caryl, Sanford Jocelyn, Jin Macy, O'Sullivan Cliona, Cummins Emma, Lambert Matthew, Sheehan Alfredo D, Ma Weijun, Gatto Scott, Kerns Kelvin, Lam Khetemenee, D'Antona Aaron M, Zhu Lily, Brady William A, Benard Susan, King Amy, He Tao, Racie Lisa, Arai Maya, Barrett Dianah, Stochaj Wayne, LaVallie Edward R, Apgar James R, Svenson Kristine, Mosyak Lidia, Yang Yinhua, Chichili Gurunadh R, Liu Liqin, Li Hua, Burke Steve, Johnson Syd, Alderson Ralph, Finlay William J J, Lin Laura, Olland Stéphane, Somers William, Bonvini Ezio, Gerber Hans-Peter, May Chad, Moore Paul A, Tchistiakova Lioudmila and Bloom Laird. Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. : Antibodies (Basel, Switzerland). 2016.